Dianthus Therapeutics Inc (NASDAQ:DNTH) currently has a daily average trading volume of 312.85K but it saw 231923 shares traded in last market. With a market cap of 560.87M USD, the company’s current market price of $17.44 came rising about 0.98 while comparing to the previous closing price of $17.27. In past 52 weeks, the stock remained buoying in the range of price level as high as $32.27 and as low as $13.36. In the recent trading on the day, stock has struck highest price mark of $16.98 while lowest mark touched by it was $17.955.
Robert W. Baird also issued its recommendations for the stock as it initiated the price target for the stock is $58.
Over the week, DNTH’s stock price is moving -3.75% down while it is -9.50% when we observe its performance for the past one month. Year-to-date it is -20.00% down and over the past year, the stock is showing a downside performance of -32.92%.
The company is expected to be releasing its next quarterly report on 2025-May-12, for which analysts forecasted an EPS of -0.89 while estimate for next year EPS is -3.49. In next quarter, company is expected to be making quarterly sales of $900.78k as analysts are expecting the sales for current fiscal year at $3.77M and seeing the company making $3.14M in sales next year. Moreover, analysts are in estimates of $864.67k for current-quarter revenue.
Currently, Dianthus Therapeutics Inc’s total number of outstanding shares is 32.13M. Company’s return on investment (ROI) stands at -30.55% and return on equity (ROE) at -28.73%. Stock’s beta reads 1.38. Stock has a price to book (P/B) ratio of 1.71 while price to sale or P/S ratio amounts to 86.02. Its return on asset (ROA) is -27.56% on average.
